Stempoint Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-101,809
Closed -$4.28M 71
2024
Q4
$4.28M Buy
+101,809
New +$4.28M 1.07% 32